241
Views
35
CrossRef citations to date
0
Altmetric
Original Article

VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans

, , &
Pages 386-390 | Received 08 Apr 2010, Accepted 10 Oct 2010, Published online: 01 Feb 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Manuel F Bande Rodríguez, Beatriz Fernandez Marta, Nerea Lago Baameiro, Maria Santiago-Varela, Paula Silva-Rodríguez, María Jose Blanco-Teijeiro, Maria Pardo Perez & Antonio Piñeiro Ces. (2020) Blood Biomarkers of Uveal Melanoma: Current Perspectives. Clinical Ophthalmology 14, pages 157-169.
Read now
Sourabh Soni & Yogendra S. Padwad. (2017) HIF-1 in cancer therapy: two decade long story of a transcription factor. Acta Oncologica 56:4, pages 503-515.
Read now
Patricia Rusa Pereira, Alexandre Nakao Odashiro, Li-Anne Lim, Cristina Miyamoto, Paula L Blanco, Macanori Odashiro, Shawn Maloney, Dominique F De Souza & Miguel N Burnier$suffix/text()$suffix/text(). (2013) Current and emerging treatment options for uveal melanoma. Clinical Ophthalmology 7, pages 1669-1682.
Read now

Articles from other publishers (31)

Peace Mabeta & Vanessa Steenkamp. (2022) The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy. International Journal of Molecular Sciences 23:24, pages 15585.
Crossref
Akif Hakan Kurt, Lokman Ayaz, Furkan Ayaz, Zeynel Seferoglu & Yahya Nural. (2022) A Review on the Design, Synthesis, and Structure-activity Relationships of Benzothiazole Derivatives against Hypoxic Tumors. Current Organic Synthesis 19:7, pages 772-796.
Crossref
Elina S. Rantala, Micaela M. Hernberg, Sophie Piperno-Neumann, Hans E. Grossniklaus & Tero T. Kivelä. (2022) Metastatic uveal melanoma: The final frontier. Progress in Retinal and Eye Research 90, pages 101041.
Crossref
Dhaval K Shukal, Pooja B Malaviya & Tusha Sharma. (2022) Role of the AMPK signalling pathway in the aetiopathogenesis of ocular diseases. Human & Experimental Toxicology 41, pages 096032712110631.
Crossref
V. G. Likhvantseva, O. A. Anurova, S. E. Astakhova, M. V. Vereshchagina, V. E. Ovanesyan & E. V. Stepanova. (2021) Expression of Vascular Endothelial Growth Factor in Uveal Melanoma. Ophthalmology in Russia 18:4, pages 914-921.
Crossref
Prisca Bustamante, Thupten Tsering, Jacqueline Coblentz, Christina Mastromonaco, Mohamed Abdouh, Cristina Fonseca, Rita P. Proença, Nadya Blanchard, Claude Laure Dugé, Rafaella Atherino Schmidt Andujar, Emma Youhnovska, Miguel N. Burnier, Sonia A. Callejo & Julia V. Burnier. (2021) Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Cristina Barbagallo, Chiara Bianca Maria Platania, Filippo Drago, Davide Barbagallo, Cinzia Di Pietro, Michele Purrello, Claudio Bucolo & Marco Ragusa. (2021) Do Extracellular RNAs Provide Insight into Uveal Melanoma Biology?. Cancers 13:23, pages 5919.
Crossref
Chun Yang, Rui Wang & Pierre Hardy. (2021) Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma. Cancers 13:20, pages 5192.
Crossref
Anna M.W. ten Voorde, Annemijn P.A. Wierenga, Rogier J. Nell, Pieter A. van der Velden, Gregorius P.M. Luyten, Robert M. Verdijk & Martine J. Jager. (2021) In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target. Cancers 13:16, pages 3986.
Crossref
Prisca Bustamante, Léo Piquet, Solange Landreville & Julia V. Burnier. (2021) Uveal melanoma pathobiology: Metastasis to the liver. Seminars in Cancer Biology 71, pages 65-85.
Crossref
Simona D’Aguanno, Fabiana Mallone, Marco Marenco, Donatella Del Bufalo & Antonietta Moramarco. (2021) Hypoxia-dependent drivers of melanoma progression. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Cen Zhang, Juan Liu, Jianming Wang, Tianliang Zhang, Dandan Xu, Wenwei Hu & Zhaohui Feng. (2021) The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Naseim Elzakra & Yong Kim. 2021. Cancer Metabolomics. Cancer Metabolomics 243 260 .
Jin Song, Zhen Zhang & Daniel W. Chan. 2021. Melanoma. Melanoma 447 459 .
Jing-Yan Yang, Yang Li, Qian Wang, Wen-Jia Zhou, Yan-Ni Yan & Wen-Bin Wei. (2020) MicroRNA-145 suppresses uveal melanoma angiogenesis and growth by targeting neuroblastoma RAS viral oncogene homolog and vascular endothelial growth factor. Chinese Medical Journal 133:16, pages 1922-1929.
Crossref
Peace Mabeta. (2020) Paradigms of vascularization in melanoma: Clinical significance and potential for therapeutic targeting. Biomedicine & Pharmacotherapy 127, pages 110135.
Crossref
Eliana B. Souto, Joana R. Campos, Raquel Da Ana, Joana F. Fangueiro, Carlos Martins-Gomes, Alessandra Durazzo, Massimo Lucarini, Elena Sánchez López, Marta Espina, Maria Luisa García, Amélia M. Silva, Fernando Mendonça, Antonello Santini & Selma B. Souto. (2020) Diabetic Retinopathy and Ocular Melanoma: How Far We Are?. Applied Sciences 10:8, pages 2777.
Crossref
Jin Song, Shannath L. Merbs, Lori J. Sokoll, Daniel W. Chan & Zhen Zhang. (2019) A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma. Clinical Proteomics 16:1.
Crossref
Tura, Pawlik, Rudolf, Ernesti, Stutzer, Grisanti & Ranjbar. (2019) Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities. Cancers 11:6, pages 868.
Crossref
Croce, Ferrini, Pfeffer & Gangemi. (2019) Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives. Cancers 11:6, pages 846.
Crossref
Dong Hyun Jo, Jin Hyoung Kim & Jeong Hun Kim. (2018) Targeting tyrosine kinases for treatment of ocular tumors. Archives of Pharmacal Research 42:4, pages 305-318.
Crossref
Hye-Youn Kim, Hwanhui Lee, So-Hyun Kim, Hanyong Jin, Jeehyeon Bae & Hyung-Kyoon Choi. (2017) Discovery of potential biomarkers in human melanoma cells with different metastatic potential by metabolic and lipidomic profiling. Scientific Reports 7:1.
Crossref
Adriana Amaro, Rosaria Gangemi, Francesca Piaggio, Giovanna Angelini, Gaia Barisione, Silvano Ferrini & Ulrich Pfeffer. (2017) The biology of uveal melanoma. Cancer and Metastasis Reviews 36:1, pages 109-140.
Crossref
Shinji Ozaki, Raja Vuyyuru, Ken Kageyama, Mizue Terai, Masahiro Ohara, Hanyin Cheng, Tim Manser, Michael J. Mastrangelo, Andrew E. Aplin & Takami Sato. (2016) Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization. The American Journal of Pathology 186:1, pages 43-56.
Crossref
Hemant Kumar & Dong-Kug Choi. (2015) Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway?. Mediators of Inflammation 2015, pages 1-11.
Crossref
Patrick Logan, Miguel Bernabeu, Alberto Ferreira & Miguel N. Burnier. (2015) Evidence for the Role of Blue Light in the Development of Uveal Melanoma. Journal of Ophthalmology 2015, pages 1-7.
Crossref
MENG YANG, XIAOCONG KUANG, YANBIN PAN, MEILE TAN, BINZHU LU, JIAN LU, QIUMEI CHENG & JIANMIN LI. (2014) Clinicopathological characteristics of vascular endothelial growth factor expression in uveal melanoma: A meta-analysis. Molecular and Clinical Oncology 2:3, pages 363-368.
Crossref
Søren K. O. Abildgaard & Henrik Vorum. (2013) Proteomics of Uveal Melanoma: A Minireview. Journal of Oncology 2013, pages 1-11.
Crossref
Shih-Chun Chao, Sheng-Chieh Huang, Dan-Ning Hu & Hung-Yu Lin. (2013) Subtoxic Levels of Apigenin Inhibit Expression and Secretion of VEGF by Uveal Melanoma Cells via Suppression of ERK1/2 and PI3K/Akt Pathways. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-9.
Crossref
Pierre L TriozziArun D Singh. (2012) Blood biomarkers for uveal melanoma. Future Oncology 8:2, pages 205-215.
Crossref
Alexandra Giatromanolaki, Efthimios Sivridis, Nikolaos E. Bechrakis, Gregor Willerding, Georgios St. Charitoudis, Michael H. Foerster, Kevin C. Gatter, Adrian L. Harris & Michael I. Koukourakis. (2011) Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival. Clinical & Experimental Metastasis 29:1, pages 11-17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.